4//SEC Filing
BIOASIA INVESTMENTS IV LLC 4
Accession 0001019687-10-000261
CIK 0001282393other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:33 PM ET
Size
14.7 KB
Accession
0001019687-10-000261
Insider Transaction Report
Form 4
BIOASIA INVESTMENTS IV LLC
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−198,487$1,094,080→ 1,209,057 total(indirect: By Biotechnology Development Fund IV, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−3,669$20,224→ 22,347 total(indirect: By Biotechnology Development Fund IV Affiliates, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−58,182$320,705→ 354,406 total(indirect: By BioAsia Crossover Fund, L.P.)
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−58,182$320,705→ 354,406 total(indirect: By BioAsia Crossover Fund, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−198,487$1,094,080→ 1,209,057 total(indirect: By Biotechnology Development Fund IV, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−3,669$20,224→ 22,347 total(indirect: By Biotechnology Development Fund IV Affiliates, L.P.)
BIOTECHNOLOGY DEVELOPMENT FUND IV LP
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−198,487$1,094,080→ 1,209,057 total(indirect: By Biotechnology Development Fund IV, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−58,182$320,705→ 354,406 total(indirect: By BioAsia Crossover Fund, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−3,669$20,224→ 22,347 total(indirect: By Biotechnology Development Fund IV Affiliates, L.P.)
BioAsia Crossover Fund LP
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−58,182$320,705→ 354,406 total(indirect: By BioAsia Crossover Fund, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−3,669$20,224→ 22,347 total(indirect: By Biotechnology Development Fund IV Affiliates, L.P.) - Sale
Common Stock
2010-01-19$5.51/sh−198,487$1,094,080→ 1,209,057 total(indirect: By Biotechnology Development Fund IV, L.P.)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The reported securities are owned directly by Biotechnology Development Fund IV Affiliates, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV Affiliates, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- [F3]The reported securities are owned directly by Biotechnology Development Fund IV, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- [F4]The reported securities are owned directly by BioAsia Crossover Fund, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of BioAsia Crossover Fund, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
Documents
Issuer
BIOFORM MEDICAL INC
CIK 0001282393
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001261786
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 8:33 PM ET
- Size
- 14.7 KB